Masatomo Takahashi

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

Shigeki Ohtake, Shuichi Miyawaki, Hiroyuki Fujita et al. · Blood · 2010 · 262 citations · Full text

Medicine, Oncology, Pharmacology +15

Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group.

Norio Asou, Koichi Adachi, Jun‐ichi Tamura et al. · Journal of Clinical Oncology · 1998 · 208 citations

Medicine, Oncology, Pharmacotherapy +14

Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study

Jin Takeuchi, Taiichi Kyo, K Naito et al. · Leukemia · 2002 · 188 citations

Medicine, Oncology, Pharmacology +14

Adiponectin/T-cadherin system enhances exosome biogenesis and decreases cellular ceramides by exosomal release

Yoshinari Obata, Shunbun Kita, Yoshihisa Koyama et al. · JCI Insight · 2018 · 182 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

Shuichi Miyawaki, Shigeki Ohtake, Shin Fujisawa et al. · Blood · 2010 · 175 citations · Full text

Medicine, Oncology, Pharmacology +15